LSP BioVentures

LSP BioVentures

LSP BioVentures

Suggest edits
Follow us
Also headquartered in Cambridge
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2021
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 8

Portfolio

Portfolio Tracker

Add info
$35,000,000 Venture capital (Series B)
PE HUB

Imcyse raises 35 mln euros

Imcyse
Imcyse
$20,000,000 Venture capital (Series B)
FinSMEs

BioClin Therapeutics Raises $20M; Completes $50M Series B Financing

Funding Health
BioClin Therapeutics
BioClin Therapeutics
$30,000,000 Venture capital (Series B)
PE HUB , Xconomy

BioClin Therapeutics inks $30 mln Series B

Messaging Funding Data leaks
BioClin Therapeutics
BioClin Therapeutics
€17,500,000 Venture capital (Series A)
FinSMEs

Immunic Closes €17.5M Series A Financing Round

Health Funding
Immunic AG
Immunic AG
€12,000,000 Venture capital (Series A)
FinSMEs

Nouscom Closes €12M in Series A Funding

Health Funding Science
Nouscom
Nouscom
€26,000,000 Venture capital (Series A)
StartupJuncture

Medtech startup G-Therapeutics gets massive €26M series A investment

Funding
g-therapeutics
g-therapeutics
$23,500,000 Venture capital (Series C)
sequanamedical

Sequana Medical AG raises CHF 23 million in a Series C financing led by LSP | experts in fluid management

Health Funding Strategy
Sequana Medical AG
Sequana Medical AG
VentureWire

The Daily Startup: Health-Administration Software Funding Hits Record

Funding
Sequana Medical AG
Sequana Medical AG
$9,300,000 Venture capital (Series C)
prnewswire

Sequana Medical AG Raises CHF 9 million (USD 9.3M) in a Series C Extension